Our findings provide evidence of the clinical relevance of MAPKAPK2 in prognosis evaluation of glioma patients and highlight the underlying significance of MAPKAPK2 in glioma therapy. This evidence concerns the gene MAPKAPK2 and central nervous system cancer.